Recovery of drug-resistant influenza A virus during therapeutic use of rimantadine
Clicks: 232
ID: 271652
1991
The therapeutic activity of rimantadine and its relationship to the shedding of drug-resistant influenza A virus were assessed in two randomized, double-blind, placebo-controlled trials involving patients with laboratory-documented influenza A virus (H3N2 subtype) illness of 2 days' duration or less …
| Reference Key |
fg1991antimicrobialrecovery
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Hayden FG;Sperber SJ;Belshe RB;Clover RD;Hay AJ;Pyke S;; |
| Journal | Antimicrobial agents and chemotherapy |
| Year | 1991 |
| DOI | DOI not found |
| URL | |
| Keywords |
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
humans
pubmed abstract
nih
national institutes of health
national library of medicine
research support
non-u.s. gov't
u.s. gov't
non-p.h.s.
adult
female
male
adolescent
middle aged
Child
Infant
P.H.S.
preschool
Clinical Trial
Randomized Controlled Trial
drug resistance
microbial
drug evaluation
influenza
human / drug therapy*
influenza a virus / drug effects
influenza a virus / isolation & purification*
f g hayden
rimantadine / therapeutic use*
pmid:1952841
pmc245261
doi:10.1128/aac.35.9.1741
s j sperber
s pyke
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.